Two cancer immunotherapy drugs being developed by Bristol-Myers and Merck proved remarkably effective against the blood cancer Hodgkin lymphoma in two small, separate studies, researchers said.
via WSJ.com: US Business http://ift.tt/15VpW7m
via WSJ.com: US Business http://ift.tt/15VpW7m
Nessun commento:
Posta un commento